Neurodevelopmental Disorders
Conference Coverage
Patients with intellectual disability require nuanced care
SAN FRANCISCO – Dr. Nita V. Bhatt talks with Dr. Julie P. Gentile about best practices for providing psychiatric interventions for patients with...
Conference Coverage
Neurodevelopmental concerns may emerge later in Zika-exposed infants
BALTIMORE – Some Zika-exposed children showed poorer mobility and social cognitive scores as they approached 18 months even though their fetal...
From the Journals
Valproate, topiramate prescribed in young women despite known teratogenicity risks
These findings suggest a lack of awareness of the teratogenic risks of valproate and topiramate on the part of physicians and patients.
From the Journals
Prenatal, postnatal neuroimaging IDs most Zika-related brain injuries
Lack of prolonged maternal viremia did not predict normal fetal or neonatal brain imaging.
Commentary
Childhood Neuromuscular Disease as a Metaphor for the Scientific Advances in Child Neurology of the Last Quarter Century
John B. Bodensteiner, MD
Dr. Bodensteiner is Director of the American Board of Psychiatry and...
From the Journals
Caffeine for apnea of prematurity found safe, effective at 11 years
At 11-year follow-up, caffeine significantly improved visuomotor, visuoperceptual, and visuospatial performance.
Conference Coverage
Conference News Roundup—American Heart Association
When a patient has a heart attack or stroke, it is critical for his or her clinician to perform a follow-up cholesterol test, according to a study...
Literature Review
CDC Updates Guidance on Infants With Possible Zika Infection
Infants with possible prenatal exposure to Zika who test positive for the virus should receive an in-depth ophthalmologic exam, intensified...
Conference Coverage
Prenatal methadone maintenance linked to poorer child neurodevelopment
SAN FRANCISCO – Motor delays appeared first, then cognitive delays.
Conference Coverage
ENDEAR Study Demonstrates Efficacy of Nusinersen in Infants With Spinal Muscular Atrophy
BOSTON—Infants with spinal muscular atrophy (SMA) type 1 who were treated with nusinersen demonstrated clinically and...
Conference Coverage
Buprenorphine is an alternative to morphine in treating NAS
SAN FRANCISCO - Buprenorphine cuts neonatal abstinence syndrome treatment time by nearly half.